Skip to main content
Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.
Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease.
Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda.
Remuscularizing the Failing Human Heart.
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia.
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease.
Corporate Vectors of Chronic Disease - Using Internal Industry Documents to Craft Counterstrategies.
An Intravenous Brain-Penetrant Enzyme Therapy for Mucopolysaccharidosis II.
Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk.
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.